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Objective: There is evidence to suggest vascular involvement in the initiation and progression of oste-
oarthritis (OA). The relationship between large artery characteristics and pathogenesis of OA has not
been investigated and was the aim of this study.
Design: Large artery characteristics (i.e., aortic stiffness, brachial and central blood pressure (BP) vari-
ables) and bone marrow lesions (BMLs; measured by magnetic resonance imaging as a surrogate index of
OA) were recorded in 208 participants (aged 63  7 years; mean  SD) with symptomatic knee OA.
Relationships between large artery characteristics and BML were assessed by multiple regression
adjusting for age, sex and body mass index.
Results: There was a high prevalence of BML presence in the study population (70%), but no signiﬁcant
difference between participants with and without BML for all large artery and BP variables (P > 0.05 all).
Furthermore, there were no signiﬁcant relationships between BML size and aortic stiffness (r ¼ 0.033,
P ¼ 0.71), central pulse pressure (r ¼ 0.028, P ¼ 0.74), augmentation index (r ¼ 0.125, P ¼ 0.14), brachial
pulse pressure (r ¼ 0.005, P ¼ 0.95) or brachial systolic BP (r ¼ 0.066, P ¼ 0.44). When participants were
stratiﬁed according to high or low aortic stiffness, there was no signiﬁcant difference between groups
regarding the proportion of those with a BML (64% vs 70% respectively; P ¼ 0.69).
Conclusions: Variables indicative of large artery characteristics are not signiﬁcantly correlated with BML
size or presence in people with symptomatic knee OA. Thus, large artery characteristics may not have a
causative inﬂuence in the development of OA, but this needs to be conﬁrmed in prospective studies.
Crown Copyright  2013 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society
International. All rights reserved.Introduction cardiovascular risk factors could advance understandingon theOAeA high proportion of patients with osteoarthritis (OA) have car-
diovascular comorbidities that have been suggested to play a
contributory role in OA pathogenesis1. Despite this, a causative
connectionbetweenOAandconventional cardiovascular risk factors
has remained elusive. Accumulating evidence alludes to vascular
involvement in the initiation and progression of OA2. Indeed, a
recent investigation found that abnormalities of the retinal micro-
vasculature were independently associated with bone marrow le-
sions (BMLs) and knee cartilage volume in a community sample of
289 asymptomatic people (61% women) aged 50e79 years3. Alto-
gether, data suggests that examination of vascular structure and
function using techniques that aremore sensitive than conventionalto: J.E. Sharman, Menzies
Private Bag 23, Hobart 7000,
.
.au (J.E. Sharman).
013 Published by Elsevier Ltd oncardiovascular disease relationship. Microvascular abnormalities
precede development of atherosclerosis and are associated with
large artery dysfunction (e.g., increased aortic stiffness)4. With this
in mind, there remains the possibility that large artery dysfunction
may also have a role in the pathogenesis of OA, but this has not been
investigated before. The aim of this study was to determine the as-
sociation betweenBMLs (as a surrogate indexofOA) and large artery
characteristics as determined by aortic stiffness and central blood
pressure (BP) variables related to systemic arterial stiffness (i.e.,
augmentation index and central pulse pressure).Methods
Participants and protocol
The study sample comprised 208 participants with symptomatic
knee OAwho were recruited as part of a clinical trial (ClinicalTrials.behalf of Osteoarthritis Research Society International. All rights reserved.
Table I
Participant characteristics between those with and without tibial or femoral BMLs
Variable BML present
(n ¼ 146)
No BML
(n ¼ 62)
P value
Age (years) 63  7 64  8 0.66
Sex (n (% male)) 75 (51) 26 (42) 0.27
Body mass index (kg/m2) 29.8  5 29.2  5 0.45
Aortic stiffness (m/s) 9.3  2 9.0  2 0.49
Peripheral systolic pressure (mmHg) 130  15 127  14 0.21
Peripheral diastolic pressure (mmHg) 74  10 72  9 0.13
Central systolic pressure (mmHg) 118  15 116  15 0.29
Peripheral pulse pressure (mmHg) 56  12 55  12 0.65
Central pulse pressure (mmHg) 43  11 43  12 0.89
Augmentation index (%) 25  10 26  9 0.46
P value is for differences between groups; values are mean  SD.
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Registry: ACTRN12610000495022)5. Data presented here is from
the baseline examination (prior to randomisation) of participants in
the Tasmanian study arm. Procedures followed were in accordance
with the ethical standards of the responsible committee on human
experimentation (institutional and national) and with the Helsinki
Declaration of 1975, as revised in 2000. All participants provided
written informed consent. Inclusion criteria were: participants
aged 50e79 years with symptomatic knee OA for at least 6 months
with a pain visual analogue scale (VAS) of at least 20 mm out of
100 mm (higher score out of 100 mm indicates more pain)6. Par-
ticipants were also required to meet the American College of
Rheumatology criteria for symptomatic knee OA assessed by a
Rheumatologist and have relatively good health (0e2 according to
the investigator’s global assessment of disease status on a 5-point
Likert scale, range 0 [very well] to 4 [very poor]). In addition,
serum 25-(OH)D levels must have ranged between 12.5 and
60 nmol/L which is in the low-normal to moderate vitamin D
deﬁciency range, using a cut-off of 50 nmol/L to deﬁne deﬁciency.
Exclusion criteria were as follows: severe radiographic knee OA,
grade 3 according to Altman’s atlas7; severe knee pain on standing
(more than 80 mm on 100 mm VAS); contraindication to MRI;
rheumatoid or psoriatic arthritis, lupus or cancer; severe cardiac or
renal impairment; hypersensitivity to vitamin D; any condition
possibly affecting oral drug absorption; signiﬁcant trauma to knees,
including arthroscopy or signiﬁcant injury to ligaments or menisci
of the knee within 1 year preceding the study; anticipated need for
knee or hip surgery within the next 2 years; history of taking
vitamin D supplements or an investigational drug within the pre-
vious 30 days.
Large artery characteristics and BP
Electrocardiogram-gated, sequential applanation tonometry at
the carotid and femoral arteries (pulse wave velocity (PWV);
SphygmoCor 8.1, AtCor Medical, Sydney, New South Wales) was
used to measure supine aortic stiffness as per recommended
guidelines8. Seated central BP was measured in duplicate by radial
tonometry using the SphygmoCor 8.1 system with a validated
transfer function9. Augmentation index was calculated from the
difference between the ﬁrst and second systolic peaks of the central
waveform as a percentage of pulse pressure8. This is a composite
measure of left ventricular load and systemic arterial stiffness.
Central pulse pressure was calculated as the difference between
central systolic and central diastolic pressure values. Seated
brachial BP was recorded in duplicate after 5 min rest using an
automated oscillometric device (Omron HEM 907) and these values
were used to calibrate the radial tonometric pressure waveform.
BMLs
An MRI scan using a T2-weighted fat-saturated fast spin echo
sequence of the symptomatic knee was undertaken for determi-
nation of tibial and femoral BMLs. A BML was deﬁned as an area of
increased signal intensity adjacent to subcortical bone in the
medial and lateral areas of the tibial and femoral bones. If more
than one BML was present, the BML of greatest size was used in
analysis. BML area was measured using Osiris software as previ-
ously described1.
Statistical methods
All analyses were performed using IBM SPSS statistics 19 for
windows. Data were expressed as mean  SD unless otherwise
stated. Pearson’s product moment correlations were used to assessrelationships between variables. Comparison of variables between
those with and without BMLs were analysed using independent
Student’s t tests or the Chi square tests for independence. Partial
correlation analysis was used to determine the relationship be-
tween BML area and large artery characteristics (aortic stiffness and
BP variables), adjusting for age, sex and body mass index. Increased
aortic stiffness was deﬁned as per age and BP-speciﬁc normative
values, calculated using standardised PWV measures10 as well as
according to the European Society of Hypertension (ESH) suggested
cutpoint of12m/s. Standard diagnostic checks of model adequacy
and unusual observations were performed for all models. BML area
was not normally distributed and was normalized by logarithmic
transformation. Statistical signiﬁcance was deﬁned as P < 0.05.
Results
Mean age of the study population was 63  7 years. BMLs were
present in 146 of the 208 participants. Characteristics of study
participants (for those with and without BMLs), as well as aortic
stiffness and BP variables are summarised in Table I. No signiﬁcant
difference in age, sex or body mass index was found between the
two groups. There was no signiﬁcant difference between partici-
pants with and without BMLs for aortic stiffness, central pulse
pressure, augmentation index or brachial pulse pressure. Further-
more, therewere no signiﬁcant relationships between BML size and
aortic stiffness (r ¼ 0.033, P ¼ 0.71), central pulse pressure
(r ¼ 0.028, P ¼ 0.74), augmentation index (r ¼ 0.125, P ¼ 0.14),
brachial pulse pressure (r ¼ 0.005, P ¼ 0.95) or brachial systolic BP
(r ¼ 0.066, P ¼ 0.44). No signiﬁcant difference in mean BML size
was found when the ESH guidelines proposed threshold for
increased aortic stiffness was used to compare groups (233  403
vs 193  241 mm2; P ¼ 0.51; Fig. 1). Furthermore, there was no
signiﬁcant difference (P ¼ 0.69) in the percentage of those with a
BML in the group with increased aortic stiffness (64%) compared
with the group of lower aortic stiffness (70%). There was also no
signiﬁcant difference in BML area for those who had aortic PWV
above calculated age- and BP-speciﬁc normative values10. These
ﬁndings were unchanged when analysed separately for men and
women.
Discussion
The aim of this study was to determine associations between
large artery characteristics and BMLs in participants with OA. The
rationale for undertaking the work was that conventional cardio-
vascular risk factors often coexist in OA, yet examination of new
(and more sensitive) large artery risk factors as potential contrib-
utory variables in OA has not been undertaken. The measurements
of large artery characteristics used in this investigation (i.e., aortic
PWV, augmentation index and central BP), are known correlates of
Fig. 1. Comparison of the total bone marrow lesion (BML) area found in tibial and
femoral bones of participants with increased aortic pulse wave velocity
(PWV  12.0 m/s; n ¼ 22) compared to those with acceptable aortic PWV (<12 m/s;
n ¼ 191) according to ESH guidelines. Error bars represent S.E.M. P ¼ 0.50 for between
group comparison.
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from conventional risk factors. The lack of association with BML
presence or size in this current work suggests that large artery
function may be less important than microvascular irregularities2,3
in the pathogenesis of OA.
Microvascular changes observed in the knees of OA patients can
include venous occlusion, venous stasis and the development of
microemboli in subchondral vessels, leading to intraosseous hy-
pertension, decreased perfusion and joint hypoxia (ischaemia)2,13.
The resultant decrease in cartilage plate nutrient supply could lead
to the formation of BMLs evident on MRI. A plausible pathway to
which large artery functional and structural changes may adversely
affect downstream vessel health has been reported in studies of the
brain, and kidneys, whereby excessive transmission of pressure
(and/or ﬂow) pulsatility (through arteries with increased stiffness)
may trigger microvascular damage and remodelling (for recent
review see Ref. 14). However, the results of this current study sug-
gest that the bonemicrovasculature may be more protected against
such damage initiated by exaggerated large artery stiffness, as
compared to the high-ﬂow, low-resistance organs such as the brain
and kidneys. Having said this, in this study we only assessed sub-
jects with established knee OA, thus we cannot comment about
disease initiation or compare ﬁndings to normal knees. Alterna-
tively, structural and mechanical knee changes associated with
ageing, altered bone loading or obesity may be more important
than large artery characteristics in determining localised blood ﬂow
in patients with OA.
Another possible explanation for the association previously
found between microvascular pathology and BML presence is
inﬂammation15. Histological signs of inﬂammation have been
observed within BMLs and arterial stiffness is associated with
markers of inﬂammation (e.g., interleukin 6 and C-reactive pro-
tein). Additionally, in inﬂammatory conditions similar to OA, a
reduction in inﬂammation with therapy has been shown to
concomitantly reduce aortic stiffness16. Thus, inﬂammation may be
a central factor associated with large artery pathology as well as
microvascular dysfunction and BMLs, but large artery abnormalities
per se may not be causing the development and progression of
BMLs. It should be noted that this cross sectional study cannotascribe causality among relationships examined. Furthermore this
study has evaluated BMLs as a surrogate measure for OA and the
ﬁndings may vary depending on the imaging biomarker used to
deﬁne OA. BMLs were measured using a T2-weighted fat saturated
sequence. Although it is accepted that this is one of the sequencing
types which depicts non-cystic lesions to their maximum extent,
correct assessment of sclerotic lesions requires non-fat saturated
T1-weighted sequences17. We suggest that future studies could
examine BMLs using both fat saturated and non-fat saturated se-
quences and acknowledge that our studymay have underestimated
sclerotic lesions.
In conclusion, this study has demonstrated that variables
indicative of large artery characteristics are not signiﬁcantly
correlated with BML size or presence in people with symptomatic
knee OA. While OA and arterial stiffness may share some aetiology,
large artery characteristics may not have a causative inﬂuence in
the development of BMLs, but this needs to be conﬁrmed in pro-
spective studies.
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